logo
Share SHARE
FONT-SIZE Plus   Neg

Santarus NDA For Inflammatory Bowel Disease Therapy Uceris Accepted By FDA

Santarus Inc. (SNTS: Quote) Wednesday reported that the United States Food and Drug Administration, or FDA, accepted for filing its New Drug Application, or NDA, seeking approval to market Uceris tablets as a therapy to induce remission of mild to moderate active ulcerative colitis. The company anticipates the completion of the FDA's review by mid-October 2012.

The NDA seeks to market Uceris in a 9 milligram, or mg, tablet. Also, Cosmo Pharmaceuticals SpA-owned Cosmo Technologies Ltd., a collaborator in the development of Uceris, is now eligible to $4 million in cash or stock as a milestone payment, Santarus Said.

A form of inflammatory bowel disease, or IBD, ulcerative colitis can cause inflammations and ulcers along the colon, resulting in such effects as diarrhea, frequent bowel movements and bleeding. About 1.4 million Americans suffer from IBDs. Uceris is the trade name for budesonide, which is a corticosteroid with topical anti-inflammatory properties.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fiat Chrysler Automobiles NV (FCAU) said an employee was killed in an accident at its Jefferson North Assembly factory in Detroit Tuesday morning. According to reports, the 53-year-old worker, whose identity has not been disclosed, was crushed in a press shortly after 7 a.m. Tuesday while working... Wang Jianlin, chairman of Dalian Wanda Group is now Asia's richest man, with a fortune of $38.1 billion. Jianlin, who holds U.S. theater chain AMC Entertainment, has also been ranked 11th richest in the world. Diversified media and entertainment conglomerate Walt Disney Co. reported Tuesday a profit for the second quarter that grew 10 percent from last year, helped by strong performance at cable networks, parks and resorts as well as sales of Frozen merch. Both adjusted earnings per share and quarterly revenues topped analysts' expectations.
comments powered by Disqus
Follow RTT